CytaCoat AB is a private Swedish company that has developed proprietary anti-microbial coatings for medical devices, with the objective of preventing healthcare-associated infections.

CytaCoat is now building a coating plant to manufacture coated devices for clinical trials. CytaCoat will license the technology to leading, established medical device players for multiple application-specific devices. CytaCoat was founded by a group of researchers from the Karolinska Institute and the Royal Institute of Technology (KTH) in Stockholm.